Drug: |
Nilotinib or Imatinib |
|||
---|---|---|---|---|
Trial: |
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1) |
|||
Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
MD Anderson Cancer Center1505 Holcombe Blvd. |
Principal Investigator: |
Jon Trent, MD, PhD |
---|---|
Contact: |
Diane Gravel 713-563-6702 dgravel@mdanderson.org Vu Ta 713-792-2848 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
MD Anderson Cancer Center Website: |
http://www.mdanderson.org/Cancer_Pro/CS_Resources/display.cfm?id=562561A1-751F-11D4-AEBD00508BDCCE3A&method=displayFull |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.